Different effects of short‐ and long‐term recombinant hGH administration on ghrelin and adiponectin levels in GH‐deficient adults
- 16 June 2004
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 61 (1) , 81-87
Abstract
Summary: objective To evaluate circulating levels of ghrelin and adiponectin (ApN) in GH‐deficient (GHD) adults before and after short‐ and long‐term recombinant human GH (rhGH) administration.patients and methods Twenty‐three patients were studied. Seventeen subjects (Group A, 12 men, five women) were evaluated at baseline and after 1 year rhGH therapy (dose mean ± SD: 0·3 ± 0·1 mg/day) with the assessment of serum IGF‐I, ghrelin, ApN, leptin, insulin and glucose levels, percentage of body fat (BF%), HOMA‐IR and QUICKI. Seventeen age‐, sex‐ and body mass index (BMI)‐matched healthy subjects were recruited for comparisons. Six patients (Group B, three men, three women) underwent IGF‐I generation test (rhGH 0·025 mg/kg/day for 7 days), blood sampled at baseline and on day 8 for determination of IGF‐I, ghrelin and ApN levels.results Group A: at baseline GHD patients showed low IGF‐I levels and BF% significantly higher than controls (31·4 ± 2·5 vs. 26·4 ± 1·3, P < 0·05). Glucose, insulin, leptin, tryglicerides, low‐density lipoprotein (LDL) and high‐density lipoprotein (HDL) cholesterol levels, as well as HOMA‐IR and QUICKI values were similar in the two series, while total cholesterol levels were higher in GHD. In GHD, ghrelin levels were significantly lower than in controls (193·9 ± 27·1 vs. 298·1 ± 32·5 pmol/l, respectively, P = 0·02), while ApN levels were similar (10·2 ± 1·1 and 9 ± 1 mg/l, respectively, P = ns). After 1 year of rhGH therapy, BF%, BMI, serum total and LDL cholesterol significantly decreased, serum leptin levels showed a trend to decrease, while HOMA‐IR and QUICKI did not change. Ghrelin and ApN levels significantly increased from 193·9 ± 27·1 to 232·4 ± 26·3 pmol/l (P < 0·01) and from 8·6 ± 0·8 to 10·3 ± 1·1 mg/l (P < 0·05), respectively. In group B, the expected increase in IGF‐I levels was associated with a significant decrease in ghrelin levels, while ApN did not change.conclusion GHD patients showed serum ghrelin lower than controls, probably due to the higher BF%. No difference in ApN was observed. Ghrelin and ApN increments induced by long‐term treatment may be related to the significant BMI and BF% reduction that is the predominant metabolic effect of rhGH therapy. Conversely, the decrease in ghrelin levels observed after short‐term rhGH administration may be consistent with an inhibitory feedback of GH and/or IGF‐I on ghrelin release.Keywords
This publication has 45 references indexed in Scilit:
- Ghrelin Can Bind to a Species of High Density Lipoprotein Associated with ParaoxonaseJournal of Biological Chemistry, 2003
- Insulin Regulates Plasma Ghrelin ConcentrationThe Journal of Clinical Endocrinology & Metabolism, 2002
- Decreased Plasma Adiponectin Concentrations in Women with DyslipidemiaThe Journal of Clinical Endocrinology & Metabolism, 2002
- Serum Adiponectin and Leptin Levels in Patients with LipodystrophiesThe Journal of Clinical Endocrinology & Metabolism, 2002
- Plasma Ghrelin Levels in Lean and Obese Humans and the Effect of Glucose on Ghrelin SecretionThe Journal of Clinical Endocrinology & Metabolism, 2002
- The IGF-I Generation Test Revisited: A Marker of GH SensitivityThe Journal of Clinical Endocrinology & Metabolism, 2001
- Stomach Is a Major Source of Circulating Ghrelin, and Feeding State Determines Plasma Ghrelin-Like Immunoreactivity Levels in HumansThe Journal of Clinical Endocrinology & Metabolism, 2001
- Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and HyperinsulinemiaThe Journal of Clinical Endocrinology & Metabolism, 2001
- Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In HumansThe Journal of Clinical Endocrinology & Metabolism, 2000
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985